Immediate Impact
2 standout
Citing Papers
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
2019 Standout
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
2018 Standout
Works of Violeta Martínez‐Robles being referenced
Azacitidine in Older Patients with Acute Myeloid Leukemia (AML). Results from the Expanded International E-Alma Series (E-ALMA+) According to the MRC Risk Index Score
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Violeta Martínez‐Robles | 36 | 6 | 9 | 6 | 2 | 36 | ||
| Silvia Bernat | 50 | 1 | 11 | 10 | 8 | 4 | 53 | |
| Fabio Lizzi | 24 | 3 | 9 | 15 | 2 | 3 | 39 | |
| M. Melin | 41 | 3 | 6 | 8 | 3 | 3 | 53 | |
| Pierre-Alexandre Baillot | 14 | 19 | 11 | 25 | 9 | 3 | 39 | |
| Ruth Richmond | 6 | 1 | 4 | 6 | 2 | 3 | 36 | |
| I Hassan | 28 | 7 | 6 | 8 | 2 | 37 | ||
| Metod Oblak | 14 | 3 | 6 | 4 | 2 | 3 | 30 | |
| James McBurney | 19 | 8 | 9 | 3 | 2 | 37 | ||
| Michal Nudel | 16 | 3 | 1 | 17 | 4 | 3 | 57 | |
| E. Alton Sartor | 16 | 3 | 14 | 8 | 5 | 4 | 42 |
All Works
Loading papers...